Literature DB >> 11216866

Bezafibrate induces acyl-CoA oxidase mRNA levels and fatty acid peroxisomal beta-oxidation in rat white adipose tissue.

M Vázquez1, N Roglans, A Cabrero, C Rodríguez, T Adzet, M Alegret, R M Sánchez, J C Laguna.   

Abstract

Rats treated with bezafibrate, a PPAR activator, gain less body weight and increase daily food intake. Previously, we have related these changes to a shift of thermogenesis from brown adipose tissue to white adipose tissue attributable to bezafibrate, which induces uncoupling proteins (UCP), UCP-1 and UCP-3, in rat white adipocytes. Nevertheless, UCP induction was weak, implying additional mechanisms in the change of energy homeostasis produced by bezafibrate. Here we show that bezafibrate, in addition to inducing UCPs, modifies energy homeostasis by directly inducing aco gene expression and peroxisomal fatty acid beta-oxidation in white adipose tissue. Further, bezafibrate significantly reduced plasma triglyceride and leptin concentrations, without modifying the levels of PPARgamma or ob gene in white adipose tissue. These results indicate that bezafibrate reduces the amount of fatty acids available for triglyceride synthesis in white adipose tissue.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11216866     DOI: 10.1023/a:1011060615234

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  37 in total

1.  Comparative studies on the influence of different fibrates on serum lipoproteins in endogenous hyperlipoproteinaemia.

Authors:  L Kłosiewicz-Latoszek; W B Szostak
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

2.  Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators.

Authors:  I Issemann; S Green
Journal:  Nature       Date:  1990-10-18       Impact factor: 49.962

Review 3.  Peroxisome proliferator activated receptors: transcriptional regulators of adipogenesis, lipid metabolism and more....

Authors:  W Wahli; O Braissant; B Desvergne
Journal:  Chem Biol       Date:  1995-05

4.  The peroxisome proliferator-activated receptor alpha (PPAR alpha) regulates the plasma thiobarbituric acid-reactive substance (TBARS) level.

Authors:  I Inoue; S Noji; M Z Shen; K Takahashi; S Katayama
Journal:  Biochem Biophys Res Commun       Date:  1997-08-28       Impact factor: 3.575

5.  Decreased susceptibility to copper-induced oxidation of rat-lipoproteins after fibrate treatment: influence of fatty acid composition.

Authors:  M Vázquez; M Merlos; T Adzet; J C Laguna
Journal:  Br J Pharmacol       Date:  1996-03       Impact factor: 8.739

6.  Assay of peroxisomal beta-oxidation of fatty acids.

Authors:  P B Lazarow
Journal:  Methods Enzymol       Date:  1981       Impact factor: 1.600

7.  Peroxisome proliferator-activated receptor alpha activation modulates cellular redox status, represses nuclear factor-kappaB signaling, and reduces inflammatory cytokine production in aging.

Authors:  M E Poynter; R A Daynes
Journal:  J Biol Chem       Date:  1998-12-04       Impact factor: 5.157

8.  Relationship between plasma lipids and palmitoyl-CoA hydrolase and synthetase activities with peroxisomal proliferation in rats treated with fibrates.

Authors:  M Alegret; R Ferrando; M Vázquez; T Adzet; M Merlos; J C Laguna
Journal:  Br J Pharmacol       Date:  1994-06       Impact factor: 8.739

9.  Weight-reducing effects of the plasma protein encoded by the obese gene.

Authors:  J L Halaas; K S Gajiwala; M Maffei; S L Cohen; B T Chait; D Rabinowitz; R L Lallone; S K Burley; J M Friedman
Journal:  Science       Date:  1995-07-28       Impact factor: 47.728

10.  Stimulation of adipogenesis in fibroblasts by PPAR gamma 2, a lipid-activated transcription factor.

Authors:  P Tontonoz; E Hu; B M Spiegelman
Journal:  Cell       Date:  1994-12-30       Impact factor: 41.582

View more
  10 in total

1.  Fenofibrate inhibits adipocyte hypertrophy and insulin resistance by activating adipose PPARalpha in high fat diet-induced obese mice.

Authors:  Sunhyo Jeong; Michung Yoon
Journal:  Exp Mol Med       Date:  2009-06-30       Impact factor: 8.718

2.  Bezafibrate lowers very long-chain fatty acids in X-linked adrenoleukodystrophy fibroblasts by inhibiting fatty acid elongation.

Authors:  Marc Engelen; Martin J A Schackmann; Rob Ofman; Robert-Jan Sanders; Inge M E Dijkstra; Sander M Houten; Stéphane Fourcade; Aurora Pujol; Bwee Tien Poll-The; Ronald J A Wanders; Stephan Kemp
Journal:  J Inherit Metab Dis       Date:  2012-03-24       Impact factor: 4.982

Review 3.  Dual and pan-peroxisome proliferator-activated receptors (PPAR) co-agonism: the bezafibrate lessons.

Authors:  Alexander Tenenbaum; Michael Motro; Enrique Z Fisman
Journal:  Cardiovasc Diabetol       Date:  2005-09-16       Impact factor: 9.951

4.  PPARs, Obesity, and Inflammation.

Authors:  Rinke Stienstra; Caroline Duval; Michael Müller; Sander Kersten
Journal:  PPAR Res       Date:  2007       Impact factor: 4.964

Review 5.  Drugs Involved in Dyslipidemia and Obesity Treatment: Focus on Adipose Tissue.

Authors:  Sofia Dias; Sílvia Paredes; Laura Ribeiro
Journal:  Int J Endocrinol       Date:  2018-01-17       Impact factor: 3.257

Review 6.  Epigenetic Regulation of Adipogenesis in Development of Metabolic Syndrome.

Authors:  Richa Pant; Priyanka Firmal; Vibhuti Kumar Shah; Aftab Alam; Samit Chattopadhyay
Journal:  Front Cell Dev Biol       Date:  2021-01-12

7.  How peroxisomes affect aflatoxin biosynthesis in Aspergillus flavus.

Authors:  Massimo Reverberi; Marta Punelli; Carrie A Smith; Slaven Zjalic; Marzia Scarpari; Valeria Scala; Giorgia Cardinali; Nicaela Aspite; Flavia Pinzari; Gary A Payne; Anna A Fabbri; Corrado Fanelli
Journal:  PLoS One       Date:  2012-10-19       Impact factor: 3.240

8.  Does the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate prevent colon cancer in patients with coronary artery disease?

Authors:  Alexander Tenenbaum; Valentina Boyko; Enrique Z Fisman; Ilan Goldenberg; Yehuda Adler; Micha S Feinberg; Michael Motro; David Tanne; Joseph Shemesh; Ehud Schwammenthal; Solomon Behar
Journal:  Cardiovasc Diabetol       Date:  2008-06-19       Impact factor: 9.951

Review 9.  Update on the use of fibrates: focus on bezafibrate.

Authors:  Ilan Goldenberg; Michal Benderly; Uri Goldbourt
Journal:  Vasc Health Risk Manag       Date:  2008

10.  Lemon Polyphenols Suppress Diet-induced Obesity by Up-Regulation of mRNA Levels of the Enzymes Involved in beta-Oxidation in Mouse White Adipose Tissue.

Authors:  Yoshiko Fukuchi; Masanori Hiramitsu; Miki Okada; Sanae Hayashi; Yuka Nabeno; Toshihiko Osawa; Michitaka Naito
Journal:  J Clin Biochem Nutr       Date:  2008-10-31       Impact factor: 3.114

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.